[1]
Wang, H. et al. 2022. EGFRmAb-modified gold nanorods reduce autophagy by disrupting the lysosomal structure for the treatment of head and neck squamous cell carcinoma. American Journal of Translational Medicine. 6, 3 (Sep. 2022), 113–123.